Skip to content
opium and hallucinogenic mushrooms

The Cabinet of Ministers in Thailand has approved a draft royal decree that allows the cultivation of opium and hallucinogenic mushrooms for medical purposes on an experimental basis.

The decree, published in the Royal Gazette, will permit the cultivation of opium within the premises of an international college in the Chiang Saen district of Chiang Rai city, under the supervision of the Narcotics Control Division. The resolution will enable the state pharmaceutical organization to obtain morphine from opium in their laboratories in Bangkok and Pathum Thani.

Furthermore, the decree allows for the cultivation of hallucinogenic mushrooms within universities or educational institutions in four regions of the country, provided that these institutions are prepared to produce antidepressants from the extract on an experimental basis. Hallucinogenic mushrooms contain two key compounds - psilocybin and psilocin - which can be used for the development of antidepressants.

The draft decree is intended to stimulate innovation and reduce the country's dependence on imported morphine and antidepressants. According to official data, from 2018 to 2020, Thailand imported morphine worth 400 million baht.

Moreover, during the period from 2015 to 2020, approximately 1.76 million people were diagnosed with depression. This information indicates that domestic production of medications will significantly reduce Thailand's expenses.

Previous article Thailand has reported its first case of death due to monkeypox.
Next article Several poisonous Chironex jellyfish have been found in the Andaman Sea near the Ao Nam Mao pier in the province of Krabi.

Leave a comment

Comments must be approved before appearing

* Required fields